ReviewCancers2025
Unlocking the Potential of Immune Checkpoint Inhibitors in HR+/HER2- Breast Cancer: A Systematic Review.
Giuseppe Di Grazia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ReviewCancers2025
Giuseppe Di Grazia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.